new indications for glp 1 drugs GLP-1/GIP RA Summary Sheet and Beyond! New Molecules and Emerging Indications
Description
Notably, DPP4is did not show an elevated danger of hypoglycemia in comparison to placebos in clinical trials, except when used together with sulphonylureas or insulin in certain studies
As of early 2025, well over 30 new GLP-1 drugs are in development
H., and Yoo S
The GH/IGF1 Axis and Signaling Pathways in the Muscle and Bone: Mechanisms Underlying Age-Related Skeletal Muscle Wasting and Osteoporosis
For patients with moderate, severe, and end-stage renal disease, a dosage adjustment is required (see Table 2 )
[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Kasina S.V.S.K., Baradhi K.M
